Study of Acupuncture as a Treatment for Joint Pain in Diverse Cancer Survivors

What this Trial Is About

Researchers are evaluating whether acupuncture is a practical treatment option for cancer survivors who experience joint pain. The study focuses on diverse underserved cancer survivors with chronic musculoskeletal pain, aiming to understand how feasible it is to enroll and treat patients with acupuncture in this population. The trial is sponsored by the Memorial Sloan Kettering Cancer Center and does not involve randomization or blinding. Participants are assigned to one of two groups. One group will receive 10 weekly acupuncture treatments over 10 weeks as a non-drug procedure. The other group will continue with standard medical care, which may include pain medications and other treatments. This non-randomized design allows comparison of acupuncture with usual care. During the study, participants will complete questionnaires and other study activities to report their pain and treatment experience. Researchers will monitor enrollment rates over the first year to measure study feasibility. The total duration of treatment involvement for acupuncture participants is 10 weeks, with ongoing monitoring of pain levels and other patient-reported outcomes. The study includes adults who speak English or Spanish and have a history of cancer with joint pain.

An Acupuncture Study for Cancer Survivors With Joint Pain